An Australian stem cell and regenerative medicine company
December 22, 2021
Diabetic foot ulcer trial now underway
Leading up to Christmas and per expectations, Cynata announced its clinical trial of CYP‑006TK in patients with diabetic foot ulcers (DFU) had commenced and is now open for patient enrolment.